Delirium is a commonly occurring complex neuropsychiatric disorder. Evidence for its treatment based on randomized controlled trials is poor. The aim of this study is to determine the efficacy and acceptability of quetiapine in the treatment of delirium
Delirium is a complex but common disorder in palliative care with a prevalence between 13 and 88 % b...
People with coronavirus disease (COVID-19) might have several risk factors for delirium, which could...
Objectives—To review the current evidence base for treating episodes of delirium in palliative care ...
Delirium is a commonly occurring complex neuropsychiatric disorder. Evidence for its treatment based...
Background Delirium is a commonly occurring complex neuropsychiatric disorder. Evidence for its tre...
Interventions for delirium have traditionally been separated into two distinct areas, non-pharmacolo...
Importance: Although several pharmacological interventions for delirium have been investigated, the...
Objective: The aim of this review was to summarize and critically evaluate the current literature re...
OBJECTIVES: Mental disorders (MDs) are disabling complications of Parkinson disease (PD). We set out...
Psychosis (delusions and/or hallucinations) is a common nonmotor feature of Parkinson’s disease (PD)...
Introduction: Delirium affects up to 80% of patients admitted to intensive care units (ICUs) and con...
This data set shows retrospective comparison of gabapentin and quetiapine in treating delirium, with...
Delirium is a complex but common disorder in palliative care with a prevalence between 13% to 88% bu...
Delirium is a frequent condition in patients in a palliative care situation and most often associate...
Background: The literature on the use of quetiapine for the treatment of bipolar disorder (BD) is li...
Delirium is a complex but common disorder in palliative care with a prevalence between 13 and 88 % b...
People with coronavirus disease (COVID-19) might have several risk factors for delirium, which could...
Objectives—To review the current evidence base for treating episodes of delirium in palliative care ...
Delirium is a commonly occurring complex neuropsychiatric disorder. Evidence for its treatment based...
Background Delirium is a commonly occurring complex neuropsychiatric disorder. Evidence for its tre...
Interventions for delirium have traditionally been separated into two distinct areas, non-pharmacolo...
Importance: Although several pharmacological interventions for delirium have been investigated, the...
Objective: The aim of this review was to summarize and critically evaluate the current literature re...
OBJECTIVES: Mental disorders (MDs) are disabling complications of Parkinson disease (PD). We set out...
Psychosis (delusions and/or hallucinations) is a common nonmotor feature of Parkinson’s disease (PD)...
Introduction: Delirium affects up to 80% of patients admitted to intensive care units (ICUs) and con...
This data set shows retrospective comparison of gabapentin and quetiapine in treating delirium, with...
Delirium is a complex but common disorder in palliative care with a prevalence between 13% to 88% bu...
Delirium is a frequent condition in patients in a palliative care situation and most often associate...
Background: The literature on the use of quetiapine for the treatment of bipolar disorder (BD) is li...
Delirium is a complex but common disorder in palliative care with a prevalence between 13 and 88 % b...
People with coronavirus disease (COVID-19) might have several risk factors for delirium, which could...
Objectives—To review the current evidence base for treating episodes of delirium in palliative care ...
DOI
Add to ORKG